This past week, the Biotechnology Innovation Organization (BIO) hosted its annual patient advocacy summit, the Patient Advocacy Changemakers Event (PACE), in Washington, D.C. The theme for this year’s summit was “Breaking Barriers to 21st Century Access,” emphasizing the importance of ensuring innovative medicines reach patients who need them.
“By putting patients first, we stay focused on why we work so hard every day to ensure that our laws and policies help forward science, innovation, and access to life-changing medicines,” said BIO President and CEO John F. Crowley. The BIO “PACE is a moment to connect one-on-one with the patient advocates who sit at the heart of our mission to advance patient-focused public policies.”
CBSA’s Vice President and Counsel for Policy + Advocacy, Amy Berenbaum Goodman, represented Colorado’s thriving life sciences ecosystem at the event and participated in a Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
